Pregnancy control in patients with systemic lupus erythematosus and antiphospholipid syndrome. Part 1: Infertility, ovarian preservation and preconception assessment. Consensus Document of the Spanish Society of Gynaecology and Obstetrics (SEGO), the Spanish Society of Internal Medicine (SEMI) and the Spanish Society of Rheumatology (SER)
Por:
Espinosa G, Galindo-Izquierdo M, Marcos Puig B, Casellas Caro M, Delgado Beltrán P, Martínez López JA, Martínez Sánchez N, Robles-Marhuenda A, Rodríguez Almaraz E, Sáez-Comet L, Ugarte A, Vela C, Bartha JL, Ruiz-Irastorza G and Martínez-Taboada VM
Publicada:
1 feb 2021
Ahead of Print:
26 nov 2019
Categoría:
Rheumatology
Resumen:
Objective: Pregnancy and puerperium are considered a risk situation in women with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). Therefore, specialised assessment is essential both preconception and during pregnancy and the puerperium. Likewise, it is very important that different specialists in autoimmune diseases and high-risk pregnancies participate in the follow-up of these patients in a coordinated manner. The Spanish Society of Gynaecology and Obstetrics, the Spanish Society of Internal Medicine, and the Spanish Society of Rheumatology have set up a working group for the preparation of three consensus documents.
Methods: The stages of the work were: distribution of work in three groups corresponding to the three periods related to pregnancy (preconception, during pregnancy and childbirth and puerperium), identification of key areas, exhaustive review of the literature and formulation of recommendations.
Results: 161 recommendations were prepared that address the three periods indicated. This first document includes the 48 recommendations that address aspects related to infertility, the need for and treatments for gonadal preservation and preconception assessment.
Conclusions: These multidisciplinary recommendations are considered decision-making tools for clinicians involved in the care of patients with SLE/APS during pregnancy. (C) 2019 Elsevier Espafia, S.L.U. and Sociedad Espanola de Reumatologia y Colegio Mexicano de Reumatologia. All rights reserved.
Filiaciones:
Espinosa G:
Department of Autoimmune Diseases, Hospital Clinic, Biological aggresion and response mechanisms, IDIBAPS, Universitat de Barcelona, Barcelona, España
Galindo-Izquierdo M:
Servicio de Reumatología, Hospital Universitario 12 de Octubre, Madrid, España
Marcos Puig B:
Servicio de Ginecología y Obstetricia, Hospital Universitario y Politécnico La Fe, Valencia, España
Casellas Caro M:
Unitat d'Alt Risc Obstètric, Vall d'Hebron Hospital Campus, Barcelona, España
Delgado Beltrán P:
Servicio de Obstetricia y Ginecología, Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, Barakaldo, Bizkaia, España
Martínez López JA:
Servicio de Reumatología, Hospital Universitario Fundación Jiménez Díaz, Madrid, España
Martínez Sánchez N:
Servicio de Obstetricia y Ginecología, Hospital Universitario La Paz, Madrid, España
Robles-Marhuenda A:
Servicio de Medicina Interna, Hospital Universitario La Paz, Madrid, España
Rodríguez Almaraz E:
Servicio de Reumatología, Hospital Universitario 12 de Octubre, Madrid, España
Sáez-Comet L:
Unidad de Enfermedades Autoinmunes Sistémicas (UEAS), Servicio de Medicina Interna, Hospital Universitario Miguel Servet, Zaragoza, España
Ugarte A:
Unidad de Enfermedades Autoinmunes, Servicio de Medicina Interna, BioCruces Bizkaia Health Research Institute, Hospital Universitario Cruces, UPV/EHU, Barakaldo, Bizkaia, España
Vela C:
Sección de Reumatología, Hospital General Universitario Alicante, Instituto de Investigación Sanitaria y Biomédica ISABIAL - FISABIO, Departamento de Medicina Clínica, Universidad Miguel Hernández, Alicante, España
Bartha JL:
Servicio de Obstetricia y Ginecología, Hospital Universitario La Paz, Madrid, España
Ruiz-Irastorza G:
Unidad de Enfermedades Autoinmunes, Servicio de Medicina Interna, BioCruces Bizkaia Health Research Institute, Hospital Universitario Cruces, UPV/EHU, Barakaldo, Bizkaia, España
Martínez-Taboada VM:
Servicio de Reumatología, Hospital Universitario Marqués de Valdecilla, IDIVAL, Facultad de Medicina, Universidad de Cantabria, Santander, España
Open Access
FULL TEXT
 |
Published Version |
This policy does not allow for Open Access for this version. |
| No Accesible |
|